ARTV$4.21+0.48%
Artiva Biotherapeutics, Inc.
Sector: Biological Products, (No Diagnostic Substances)Industry: BiotechnologyCountry: USExchange: Nasdaq
Mkt Cap:$205.83M
Float & O/S:
Inst Own:
DilutionScan read 52 of Artiva Biotherapeutics, Inc.'s SEC filings and found 1 warrant series, 2 ATM programs, 2 shelf registrations and 1 completed offering on file for ARTV. The latest dilution event on file is a registration statement on Aug 14, 2026. Analysis updated Oct 31, 2026.
